Zebra Capital Management LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 170 filers reported holding ANTARES PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
Zebra Capital Management LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q4 2021$222,000
-15.9%
61,984
-14.3%
0.36%
+10.9%
Q3 2021$264,000
+112.9%
72,365
+154.5%
0.32%
+120.7%
Q2 2021$124,000
+6.0%
28,4380.0%0.14%
+12.4%
Q1 2021$117,000
-79.7%
28,438
-80.3%
0.13%
-82.4%
Q4 2020$576,000
+40.8%
144,326
-4.9%
0.73%
+15.7%
Q3 2020$409,000
+111.9%
151,729
+116.7%
0.63%
+127.3%
Q2 2020$193,000
-3.5%
70,012
-17.6%
0.28%
-13.9%
Q1 2020$200,000
-49.0%
84,963
+1.7%
0.32%
-7.2%
Q4 2019$392,00083,5680.35%
Other shareholders
ANTARES PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders